International Standard Serial Number (ISSN)
publication venue for
Effect of Prophylaxis for Early Adrenal Insufficiency Using Low-Dose Hydrocortisone in Very Preterm Infants: An Individual Patient Data Meta-Analysis.
Impact of Erythropoiesis-Stimulating Agents on Behavioral Measures in Children Born Preterm.
Validation of Test Weighing Protocol to Estimate Enteral Feeding Volumes in Preterm Infants.
Growth Outcomes of Preterm Infants Exposed to Different Oxygen Saturation Target Ranges from Birth.
Hydrocortisone Dosing for Hypotension in Newborn Infants: Less Is More.
Nonsuicidal self-injury among youth.
Postdiarrheal Hemolytic Uremic Syndrome in United States Children: Clinical Spectrum and Predictors of In-Hospital Death.
Respiratory outcomes of the surfactant positive pressure and oximetry randomized trial (SUPPORT).
Hypotension following patent ductus arteriosus ligation: the role of adrenal hormones.
Cutaneous clues: a genetic disorder diagnosed by dermatologic findings.
Not just a diaper rash: LUMBAR syndrome.
Blotchy baby: a case of phakomatosis pigmentovascularis.
Perinatal asphyxia with hyperoxemia within the first hour of life is associated with moderate to severe hypoxic-ischemic encephalopathy.
Are outcomes of extremely preterm infants improving? Impact of Bayley assessment on outcomes
Effect of ethnicity and race on cognitive and language testing at age 18-22 months in extremely preterm infants.
Feasibility study of early blood pressure management in extremely preterm infants.
Improving the Neonatal Research Network annual certification for neurologic examination of the 18-22 month child.
Risk factors for post-neonatal intensive care unit discharge mortality among extremely low birth weight infants.
Violence in media research.
. 156:168-9; author reply 169-70.
Long-term budesonide or nedocromil treatment, once discontinued, does not alter the course of mild to moderate asthma in children and adolescents.
First do no harm: why have parents and pediatricians missed the boat on children and media?
Erythropoiesis Stimulating Agents Demonstrate Safety and Show Promise as Neuroprotective Agents in Neonates.
Dexamethasone and the brain at age 18 years: randomize the first baby--and follow-up.